Improving patient access to biosimilar tumor necrosis factor inhibitors in immune-mediated inflammatory disease: lessons learned from Norway

.

Source: Expert Opinion on Biological Therapy - October 24, 2023 Category: Drugs & Pharmacology Authors: Guro L GollTore K Kviena Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norwayb Institute of Clinical Medicine, University of Oslo, Oslo, Norway Source Type: research